Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yefeng
Contact Yefeng, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Enhancing Photoelectrochemical Water Oxidation on WO3 via Electrochromic Modulation: Universal Effects and Mechanistic Insights
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description smll202402474-sup-0001-SuppMat.docx6 MB Supporting Information References 1, , , , , Adv. Funct. Mater. 2019, 29, 1809036. 2, , , , , , Chem. Soc. Rev. 2013, 42, 2228. 3, , , , , , Angew. Chem., Int. Ed. 2016, 55, 11819. 4, , , , , , , ACS Nano 2014, 8, 11770. 5, , , , , Adv. Energy Mater. 2018, 8, 1800210. 6, , , , , , , , , , , Nanoscale 2019, 11, 18968. 7, , , , , , , , ACS Catal. 2018, 8, 10573.
Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review
Introduction Pulmonary sarcomatoid carcinoma (PSC) is a rare, poorly differentiated, highly invasive subtype of non-small cell lung cancer (NSCLC) with a dismal prognosis (1). PSC accounts for 0.1%-0.4% of NSCLC cases, with median survival ranging from 11 to 19 months and a 5-year survival rate between 17% and 29% (2).
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Yefeng
Contact Yefeng, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack